MPN clinical trials are open studies that test the long-term safety, tolerability, and efficacy of Givinostat in patients with Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis following core protocols. There are several types of cancer clinical trials, prevention trials, screening trials, supportive and palliative care trials, and natural history studies.
The benefits of a clinical trial are getting a new treatment for a disease before it is available to everyone, and you play a more active role in your health care concerns. The potential risks of a clinical trial are serious side effects; the new treatment may not work. Tips for taking a clinical trial are exercising regularly, eating healthy, reducing stress, and drink plenty of water.
To conclude, talk to your doctor soon and find out if a clinical trial would work for you.